Related references
Note: Only part of the references are listed.High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis
Khalil Bourji et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis
Michal Ciurzynski et al.
CLINICAL RHEUMATOLOGY (2014)
Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound
Elena Schiopu et al.
RHEUMATOLOGY (2014)
Improvement of plasma endothelin-1 and nitric oxide in patients with systemic sclerosis by bosentan therapy
Shin-ya Kawashiri et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis
Esen Savas et al.
WIENER KLINISCHE WOCHENSCHRIFT (2014)
Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial
Marcelo Jose Uchoa Correa et al.
REVISTA BRASILEIRA DE REUMATOLOGIA (2014)
N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma
C. -F. Zhou et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2013)
Oxidative stress in Mexicans with diffuse cutaneous systemic sclerosis
M. P. Cruz-Dominguez et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study
Maurizio Turiel et al.
ARTHRITIS CARE & RESEARCH (2013)
Erythrocyte glutathione transferase: a non-antibody biomarker for systemic sclerosis, which correlates with severity and activity of the disease
R. Fabrini et al.
CELL DEATH & DISEASE (2013)
Serum Homocystein Level in Patients With Scleroderma
Mohammadali Nazarinia et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL (2013)
Serum antioxidant status in patients with systemic sclerosis
Iffat Hassan et al.
INDIAN JOURNAL OF DERMATOLOGY (2013)
Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis
Fumihide Ogawa et al.
CLINICAL RHEUMATOLOGY (2011)
Early Detection of Cardiac Involvement in Systemic Sclerosis Assessed by Tissue-Doppler Echocardiography: Relationship with Neurohormonal Activation and Endothelial Dysfunction
Theodoros Dimitroulas et al.
JOURNAL OF RHEUMATOLOGY (2010)
Survival in Pulmonary Hypertension Associated With the Scleroderma Spectrum of Diseases Impact of Interstitial Lung Disease
Stephen C. Mathai et al.
ARTHRITIS AND RHEUMATISM (2009)
Plasma Homocysteine Levels, The Prevalence of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Macrovascular Disorders in Systemic Sclerosis: Risk Factors for Accelerated Macrovascular Damage?
Szilvia Szamosi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2009)
Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse
Amelie Servettaz et al.
JOURNAL OF IMMUNOLOGY (2009)
Correlation of Biomarkers of Endothelium Dysfunction and Matrix Remodeling in Patients with Systemic Sclerosis
Sophie Blaise et al.
JOURNAL OF RHEUMATOLOGY (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Exhaled nitric oxide, but not serum nitrite and nitrate, is a marker of interstitial lung disease in systemic sclerosis
Kiet Phong Tiev et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2009)
A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: Coronary artery calcification in cases and controls
Vandana Khurma et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Antioxidant defense capacity in scieroderma patients
Roxana Sfrent-Cornateanu et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension
T. Dimitroulas et al.
RHEUMATOLOGY (2008)
Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin
J. Wipff et al.
RHEUMATOLOGY (2008)
Serum nitric oxide metabolites and disease activity in patients with systemic sclerosis
Mo Yin Mok et al.
CLINICAL RHEUMATOLOGY (2008)
Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis
Valeria Riccieri et al.
CLINICAL RHEUMATOLOGY (2008)
Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis
Alexandra Balbir-Gurman et al.
CLINICAL RHEUMATOLOGY (2007)
Correlation between homocysteine plasma levels and nailfold videocapillaroscopic patterns in systemic sclerosis
Paola Caramaschi et al.
CLINICAL RHEUMATOLOGY (2007)
The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement
Benan Musellim et al.
RHEUMATOLOGY INTERNATIONAL (2006)
Oxidative stress parameters in different systemic rheumatic diseases
Omidreza Firuzi et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine
A. Dooley et al.
RHEUMATOLOGY (2006)
Lipid peroxidation and trace elements in systemic sclerosis
M Tikly et al.
CLINICAL RHEUMATOLOGY (2006)
Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis
D Peterlana et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2006)
Levels of F2-isoprostanes in systemic sclerosis:: correlation with clinical features
A Volpe et al.
RHEUMATOLOGY (2006)
NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity
Yasushi Kawaguchi et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Endothelin-1 response to mental stress in early ischemic lesions of the extremities due to systemic sclerosis
F Fontana et al.
PEPTIDES (2005)
Effects of short-term treatment with vitamin E in systemic sclerosis: a double-blind, randomized, controlled clinical trial of efficacy based on urinary isoprostane measurement
JL Cracowski et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis
Y Allanore et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1
Y Allanore et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features
K Takagi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis
R Kalfin et al.
FREE RADICAL RESEARCH (2002)
Low levels of nitric oxide (NO) in systemic sclerosis:: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells
Y Allanore et al.
RHEUMATOLOGY (2001)
Share Paper
